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ABSTRACT  
Background: Breast cancer has   shown an increased prevalence worldwide, both in 
industrialized and developing countries. Unfortunately, most cancers do not produce any 
symptoms until the tumors   are either too large to be removed surgically or metastasis has 
taken place. Therefore, there is need for simple biochemical investigations, which can be 
easily assayed, less expensive and can predict stages and prognosis. This study was 
undertaken to know   the usefulness of estimation of serum Alkaline Phosphatase (ALP) in 
assessing the prognosis and staging of breast cancer in smaller laboratories where 
sophisticated technology is not available. Materials & Methods: A total number of 95 
subjects participated in the present study which included 60 breast cancer cases and 35 
controls. Serum Alkaline Phosphatase levels were estimated in preoperative & postoperative 
breast cancer subjects of different stages and control. ALP Levels were compared between 
control and breast cancer. Also comparison was done between different stages and further, 
ALP levels compared pre and post operatively. Results: Rise in the ALP was found in breast 
cancer when compared to controls. ALP levels increased significantly with the stage of cancer. 
Postoperatively, there was significant decrease in ALP levels in each stage. Conclusion: 
Though less sensitive than imaging procedures, measurement of serum ALP is cost effective 
and may be useful in smaller laboratories for staging, to know the prognosis and monitor the 
treatment. Serial analysis using plasma Alkaline phosphatase isoenzymes combined with 
other parameters like Gamma glutamyl transferase (GGT) for the detection of metastasis 
would seem to be justified. 
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INTRODUCTION 
Breast cancer is one of the diseases most feared by women 
and perceived as fatal world wide. In India breast cancer 
accounts for 27.0 percent  of all malignant cases (an incidence 
rate of 25.8 per lakh  & mortality rate being 12.7/lakh 
population)[1]. Breast tumor in women has shown an 
increased prevalence worldwide, both in industrialized and 
developing countries. Various theories propounded are based 
on altered hormonal milieu, personal and demographic 
factors and certain agents such as radiant energy, oncogenic 
viruses and chemical carcinogens which induces neoplastic 
transformation of the cell.[2]  
Educating the women about the value of periodic self 
examination of the breast will help in detection of breast 
cancer in early stage. Cancer that is detected early can 
potentially be cured when the tumor is small enough to be 
completely removed surgically. Unfortunately, most cancers 
do not produce any symptoms until the tumors   are either 
too large to be removed surgically or cancerous cells have 
already spread to other tissues i.e., metastasis has taken 
place[3]. Therefore, there is a need for noninvasive and 
sensitive methods to detect growths small in size which 
escape routine examination. This could be achieved to a 
certain extent by measuring products and metabolites 
derived from the tumors in the body. There are many non 
specific markers that are studied in breast cancer when 
compared to more specific markers like BRCA gene & CA 15-
3. However estimation of more specific markers are costlier 
and is not available  in the peripheral labs due to the cost and 
equipments. Some of the non specific markers that are 
studied are Lactate dehydrogenase, Alkaline phosphatase, 
ferritin  and gamma glutamyl transpeptidase etc[4]. Therefore, 
there is need for simple biochemical investigations, which can 
be easily assayed, less expensive and can predict stages and 
prognosis. This study was undertaken to study the importance 
of ALP in Breast cancer with and without metastasis in women 
and to know  the usefulness of estimation of ALP in assessing 
the prognosis of breast cancer. 
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MATERIAL AND METHODS 
A total number of 95 subjects participated in the present 
study which included 60 breast cancer cases and 35 controls. 
All were in the age group of 25 to 80 years. Study was 
conducted on inpatients and out patients of Chigateri General 
Hospital and Bapuji Hospital (both hospitals attached to J.J.M 
Medical College, Davangere, India) and also from the general 
population in and around Davangere. Informed consent was 
taken from each subject and the study was approved by the 
ethical committee. The patients and controls voluntarily 
participated in the study.  
Cases were histopathologically diagnosed breast cancer 
cases. Patients with myocardial infarction, jaundice or liver 
disease, pancreatic disease, diabetes mellitus and those 
taking anti-epileptic or hepatotoxic drugs during the last three 
months were excluded from the study. A careful history was 
taken and thorough clinical examination was conducted in all 
the cases according to the proforma. Routine investigations 
was done in all cases. Breast cancer patients were divided into 
4 groups according to stage grouping. Stage grouping was 
based on TNM staging system. About 6ml of blood was drawn 
in a fasting condition with aseptic precaution from a large 
peripheral vein (usually cubital vein) and collected in a sterile 
bulb. Serum was separated by centrifugation and kept at 40C 
until analysis was carried out. Serum levels of Alkaline 
phosphatase was measured preoperatively, and post 
operatively on 7th day in 60 cases of breast cancer.  Total 
serum alkaline phosphatase activity was determined by 
recommended method of the committee on the enzymes of 
the Scandinavian society of clinical chemistry and clinical 
physiology using 4-nitrophenylphosphate as substrate at 370c 
with absorbance reading at 405 nm[5]. 
STATISTICAL ANALYSIS 
All the measurements were expressed as mean  SD and 
range values. Unpaired ‘t’ test was used for finding the 
significant difference between two groups. One-way ANOVA 
was used for multiple group comparison. In carcinoma 
patients, changes in the serum levels of biochemical 
parameter after surgery was analyzed by paired-t test for each 
stage. For all the tests p-value of <0.05 was considered as 
statistically significant. 
RESULTS 
Table 1. Comparison of mean serum Alkaline phosphatase 
(ALP) levels in controls & breast cancer patients. 
STAGES N MEAN±SD RANGE 
CONTROL 35 94.85±25.13 41.2 – 140.3 
I 11 135.36±22.11 111.2 – 180.1 
II 18 167.16±13.59 148.1 – 188.8 
III 18 298.21±18.44 271.0 – 333.5 
IV 13 415.08±30.35 374.1 – 456.2 
  
TABLE 2: Comparison of serum ALP between the stages of 
cancer preoperatively (PRE-OP) (ANOVA TEST) 
GROUPS 
COMPARED 
MEAN 
DIFFERENCE 
SIGNIFICANCE F - VALUE 
STAGE 1 – 
STAGE 2 
31.80 0.001, HS 
 
497.88 
 
STAGE 1 – 
STAGE 3 
162.84 <0.001, HS 
STAGE 1 – 
STAGE 4 
279.71 <0.001, HS 
STAGE 2 – 
STAGE 3 
131.04 <0.001, HS 
576.74 
STAGE 2 – 
STAGE 4 
251.33 <0.001, HS 
STAGE 3 – 
STAGE 4 
116.87 <0.001, HS t-VALUE: 
12.34 * 
*INDEPENDENT/UNPAIRED t TEST 
TABLE 3. Comparison of serum ALP levels in PRE-OP AND 
POST-OP in different stages (PAIRED t TEST) 
STAGES N MEAN± SD 
t -
VALUE 
SIGNIFIC
ANCE 
I 
PRE-OP 11 135.36±22.11 
1.58 0.145, NS 
POST-OP 11 130.76±27.85 
II 
PRE-OP 18 167.16±13.59 
10.97 
<0.001, 
HS POST-OP 18 129.97±7.45 
III 
PRE-OP 18 298.21±18.44 
22.75 
<0.001, 
HS POST-OP 18 211.56±9.54 
I
V 
PRE-OP 13 415.08±30.35 
14.96 
<0.001, 
HS POST-OP 13 265.51±17.65 
 
Figure 1. Showing number of cases in different stages 
DISCUSSION 
Alkaline phosphatase (ALP) is a serum enzyme whose total 
levels reflect the combined activity of several isoenzymes 
found in the liver, bone, kidney, and intestinal lining[6]. ALP 
has consistently been shown to predict bone metastases, and 
to some extent liver metastases, as expected on the basis of 
its biologic activity. While some studies have reported fairly 
high sensitivity of ALP for bone and overall metastases 
detection, these studies included the use of specific 
18%
30%30%
22%
STAGE I STAGE II STAGE III STAGE IV
Chandrakanth KH et al.  14 
 
Int J Clin and Biomed Res. 2016;2(1): 13-15 
isoenzymes in addition to total ALP[7].Elevation of serum ALP 
occurs because of the accelerated de novo synthesis of the 
enzyme and subsequent regurgitation into the serum[8,9,10]. 
The present study showed increased total ALP in breast 
cancer when compared to control. And also, serum ALP levels 
increased significantly as the stage of the cancer progressed. 
The increased ALP noticed in our study also indicates that the 
disease had metastasized to bone or liver. According to the 
study conducted by the   International Breast Cancer Study 
Group (IBCSG), ALP alone was abnormal in a high proportion 
of breast cancer patients with bone metastases and/or liver 
metastases, and was more effective than AST and GGT in 
distinguishing patients with relapse from those without[11].  
Coombes  et al[12] also suggested that, of all the biochemical 
determinants available in the clinical laboratory, 
measurement of plasma total alkaline phosphatase, gamma-
glutamyltransferase activity, and carcinoembryonic 
antigen(CEA) concentration are the most useful for detecting 
overt metastatic deposits. 
Vanhoof et al. (1992)[13] and Stieber et al.(1992)[14] did not find 
any significant difference in ALP levels in  non-metastatic 
breast cancer, despite the fact that some others have also 
revealed a significant rise in ALP in metastasis (Ramaswamy et 
al. 2000[15]; Lamerz et al. 1993[16]) suggesting involvement of 
bone and liver.   Findings in present study is similar to resent 
study of A K Sing et al (2013) [17] also found significant rise of 
ALP levels in different stages of cancer.  Mishra et al (2004) [18] 
also found persistent rise of ALP levels in metastasis. 
From our study it is observed that serum alkaline phosphatase 
analyzed 7 days after surgery showed significant decrease in 
serum levels. This may be due to removal of cancer tissue. B. 
Prabasheela et al (2012)[19] and Keshaviah et al[6] have noticed 
increased ALP activity in some of the cases after surgery, 
which might be due to recurrence. However, in the present 
study 7 days of surgery is a very short duration of follow up. 
To establish prognostic importance, a longer duration follow 
up is needed. 
CONCLUSION 
Our study reveals higher ALP levels in breast cancer when 
compared to controls. Progressive increase in serum ALP in 
the study may be due to metastasis. Serial analysis using 
plasma Alkaline phosphatase isoenzymes combined with 
other parameters like Gamma glutamyl transferase (GGT) for 
the detection of metastasis would seem to be justified. Such 
measurements, though less sensitive than imaging 
procedures, can assist in screening for, early detection of a 
considerable proportion of metastasis and   to monitor the 
treatment in breast cancer. Study indicates measurement of 
serum ALP is cost effective and may be useful in smaller 
laboratories where sophisticated laboratory and reliable 
cancer marker are not available.  
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